hepatitis%20a%20-and-%20e
HEPATITIS A & E

Hepatitis A route of transmission is through oral-fecal route while in hepatitis E, aside from the oral-fecal route, it is also transmitted through blood transfusion in endemic areas.

Hepatitis A incubation period is 15-50 days and hepatitis E incubation period is 15-60 days.

Hepatitis A & E viruses cause epidemics.

 

Hepatitis%20a%20-and-%20e Patient Education

Patient Education

Partner Notification

  • Partner notification should be performed for at-risk sexual contacts (oral/anal, digital/rectal, and penetrative anal sex) within 2 weeks before to 1 week after the onset of jaundice

Patient Education

  • Provide the patient with a detailed explanation of his condition
    • Provide clear, accurate, written information
  • Advise patient to take adequate rest, nutrition and fluids during the course of the illness and alcohol intake should be avoided 
  • Patients must avoid food handling and unprotected sexual intercourse until they become noninfectious because transmission of hepatitis A is mainly by the oral-fecal route
  • Screen for other sexually transmitted diseases (STDs) in cases of sexually acquired hepatitis or if otherwise appropriate

Prevention

  • Drink only purified water when traveling; boiled or chlorinated water may also be considered
  • Avoid eating raw pork, venison and shellfish; cooking meat at >185°F or >85°C for 1 minute may help kill hepatitis viruses
  • Good hand hygiene should also be observed
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Gastroenterology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Audrey Abella, 25 Nov 2020
Reductions in liver fat and adipose tissue volumes were sustained in patients with type 2 diabetes (T2D) with the addition of the SGLT-2* inhibitor dapagliflozin (DAPA) and the DPP-4** inhibitor saxagliptin (SAXA) to metformin (MET), compared with a regimen comprising glimepiride (GLIM)+MET, according to the extension period results of a phase IIIb trial.